NeoGenomics (NEO) director Carolyn Starrett files initial Form 3

Rhea-AI Filing Summary

NEOGENOMICS INC director Carolyn S. Starrett filed an initial Form 3, which is a required statement of beneficial ownership for insiders. The filing shows no reported transactions or holdings at this time, indicating it is an initial disclosure establishing her status as a reporting person.

Key Figures

Buy transactions: 0 shares Sell transactions: 0 shares Derivative exercises: 0 shares +1 more

4 metrics

Buy transactions 0 shares Form 3 transaction summary buyShares

Sell transactions 0 shares Form 3 transaction summary sellShares

Derivative exercises 0 shares Form 3 transaction summary exerciseShares

Net buy/sell shares 0 shares Form 3 transaction summary netBuySellShares

Key Terms

Form 3, beneficial ownership, reporting person, derivative positions

4 terms

Form 3 regulatory

"filed an initial Form 3, which is a required statement of beneficial ownership"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership financial

"an initial Form 3, which is a required statement of beneficial ownership for insiders"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

reporting person regulatory

"establishing her status as a reporting person"

derivative positions financial

"It is an initial ownership statement and reports no stock transactions or derivative positions"

Derivative positions are contracts that derive their value from an underlying asset—such as a stock, bond, currency or commodity—and include instruments like options, futures and swaps. Think of them as bets or insurance tied to an asset’s future price: they let investors amplify returns, hedge risk or take exposure without owning the asset directly, which can meaningfully increase potential gains, losses and volatility in a portfolio.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Available on EDGAR 06/25/2026 - 04:10 PM Accepted by SEC EDGAR 06/25/2026 - 04:08 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Starrett Carolyn S

(Last) (First) (Middle)

9490 NEOGENOMICS WAY

(Street)

FORT MYERS FLORIDA 33912

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/23/2026

3. Issuer Name and Ticker or Trading Symbol
NEOGENOMICS INC [ NEO ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

No securities are beneficially owned.

	/s/ Ali Olivo, Attorney-in-Fact	06/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Carolyn S. Starrett’s Form 3 filing mean for NEO?

The Form 3 shows Carolyn S. Starrett has become a reporting insider at NeoGenomics Inc. It is an initial ownership statement and reports no stock transactions or derivative positions in this filing.

Did Carolyn S. Starrett buy or sell NeoGenomics (NEO) shares in this Form 3?

No transactions are reported in this Form 3 for Carolyn S. Starrett. The transaction summary shows zero buy, sell, exercise, gift, tax-withholding, or restructuring activity and a neutral net buy/sell direction.

What role does Carolyn S. Starrett have at NeoGenomics (NEO)?

Carolyn S. Starrett is identified as a director of NeoGenomics Inc. Directors are considered insiders and must file Forms 3, 4, and 5 to disclose their beneficial ownership and any subsequent trading activity.

Does this NeoGenomics Form 3 show any derivative securities or options?

No derivative positions are reported in this Form 3. The derivative summary is empty, and derivativeTransactionCount and exerciseCount are both zero, indicating no options or other derivatives are disclosed here.

What does a neutral net buy/sell direction indicate in NEO’s Form 3?

A neutral net buy/sell direction means there were no net share purchases or sales reported. In this Form 3, all transaction counts and share amounts are zero, so it simply reflects the absence of any trading activity.